AGUIRRE FERNANDO

SEC source: 0001127602-21-029714 · form4.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,244

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

SEC source: 0001601712-21-000308 · wf-form4_163710001694070.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,189

F1 · shares: Represents dividend equivalent units accrued on November 12, 2021 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

F1 · price: Represents dividend equivalent units accrued on November 12, 2021 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

SEC source: 0001601712-21-000275 · wf-form4_163337922092993.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,174

F1 · date: Represents restricted stock units that will vest in full on September 30, 2022. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock.

SEC source: 0001601712-21-000239 · wf-form4_162914723402502.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,330

F1 · shares: Represents dividend equivalent units accrued on August 12, 2021 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

F1 · price: Represents dividend equivalent units accrued on August 12, 2021 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

SEC source: 0001601712-21-000224 · wf-form4_162523202472731.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,314

F1 · date: Represents restricted stock units that will vest in full on June 30, 2022. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock.

SEC source: 0001601712-21-000185 · wf-form4_162128172699538.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,618

F1 · shares: Represents dividend equivalent units accrued on May 13, 2021 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

F1 · price: Represents dividend equivalent units accrued on May 13, 2021 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

SEC source: 0001127602-21-016895 · form4.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,991

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

SEC source: 0001601712-21-000163 · wf-form4_161739534109635.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,595

F1 · date: Represents restricted stock units that will vest in full on March 31, 2022. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock.

SEC source: 0001601712-21-000100 · wf-form4_161368357548554.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,764

F1 · shares: Represents dividend equivalent units accrued on February 16, 2021 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

F1 · price: Represents dividend equivalent units accrued on February 16, 2021 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

SEC source: 0001601712-21-000022 · wf-form4_160988359887075.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,729

F1 · date: Represents restricted stock units that will vest in full on December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock.

SEC source: 0001127602-20-029743 · form4.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,612

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

SEC source: 0001601712-20-000294 · wf-form4_160556142899830.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,756

F1 · shares: Represents dividend equivalent units accrued on November 12, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

F1 · price: Represents dividend equivalent units accrued on November 12, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

SEC source: 0001601712-20-000244 · wf-form4_160167576988792.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,711

F1 · date: Represents restricted stock units that will vest in full on September 30, 2021. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock.

SEC source: 0001601712-20-000219 · wf-form4_159769585303657.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,421

F1 · shares: Represents dividend equivalent units accrued on August 13, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

F1 · price: Represents dividend equivalent units accrued on August 13, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

SEC source: 0001601712-20-000190 · wf-form4_159372124208081.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,373

F1 · date: Represents restricted stock units that will vest in full on June 30, 2021. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock.

SEC source: 0001601712-20-000160 · wf-form4_158983251144906.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,849

F1 · shares: Represents dividend equivalent units accrued on May 14, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

F1 · price: Represents dividend equivalent units accrued on May 14, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

SEC source: 0001127602-20-016766 · form4.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,860

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

SEC source: 0001601712-20-000139 · wf-form4_158801812917804.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trusts

Disclosed balance after: 15,300

F1 · ownership.nature: Represents shares of Synchrony Financial common stock purchased by trusts for the benefit of the reporting person and his family members. The reporting person serves as the trustee of the family trusts.

SEC source: 0001601712-20-000112 · wf-form4_158585928095414.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,800

F1 · date: Represents restricted stock units that will vest in full on March 31, 2021. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock.

SEC source: 0001601712-20-000065 · wf-form4_158205975833468.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,702

F1 · shares: Represents dividend equivalent units accrued on February 13, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

F1 · price: Represents dividend equivalent units accrued on February 13, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

SEC source: 0001601712-20-000013 · wf-form4_157809023992975.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,691

F1 · date: Represents restricted stock units that will vest in full on December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock.

SEC source: 0001127602-19-033570 · form4.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,995

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

SEC source: 0001601712-19-000278 · wf-form4_157411278651099.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 753

F1 · shares: Represents dividend equivalent units accrued on November 14, 2019 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

F1 · price: Represents dividend equivalent units accrued on November 14, 2019 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

SEC source: 0001601712-19-000235 · wf-form4_157004736625516.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 749

F1 · date: Represents restricted stock units that will vest in full on September 30, 2020. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock.

SEC source: 0001127602-19-019156 · form4.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,444

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

SEC source: 0001127602-19-010792 · form4.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,222

F1 · price: Represents weighted average purchase price for this group of purchases, which occurred on the same day. Multiple purchases were conducted, with prices ranging between $53.58 and $53.61 per share.

SEC source: 0001127602-19-009473 · form4.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,322

F1 · price: Represents weighted average price for this group of purchases, which occurred on the same day. Multiple purchases were executed, with prices ranging between $58.28 and $58.31 per share.

SEC source: 0001122304-18-000168 · edgar.xml · derivative · entry 4

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,327.7396 shares

Expires not disclosed

F4 · derivative.exercise_price: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

F4 · price: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

F4 · derivative.exercise_date: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

F4 · derivative.expiration_date: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

SEC source: 0001122304-18-000168 · edgar.xml · derivative · entry 3

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 990 shares

Expires not disclosed

F3 · derivative.exercise_price: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

F3 · price: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

F3 · derivative.exercise_date: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

F3 · derivative.expiration_date: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

SEC source: 0001122304-18-000168 · edgar.xml · derivative · entry 2

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Previously reported Units granted under the Non-Employee Director Compensation Plan (the "Plan"). These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

F2 · price: Previously reported Units granted under the Non-Employee Director Compensation Plan (the "Plan"). These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

F2 · derivative.exercise_date: Previously reported Units granted under the Non-Employee Director Compensation Plan (the "Plan"). These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

F2 · derivative.expiration_date: Previously reported Units granted under the Non-Employee Director Compensation Plan (the "Plan"). These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

SEC source: 0001122304-18-000168 · edgar.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.

SEC source: 0001127602-18-034861 · form4.xml · nonDerivative · entry 2

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,912

F2 · shares: Consists of common stock issued as a pro rata portion of the retainer payable for the reporting person's 2018-2019 Board service, pursuant to the Registrant's 2017 Incentive Compensation Plan.

SEC source: 0001127602-18-034861 · form4.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,604

F1 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of December 3, 2017 (the "Merger Agreement"), by and among CVS Health Corporation ("CVS Health"), Hudson Merger Sub Corp. (the "Merger Sub"), a wholly owned subsidiary of CVS Health, and Aetna Inc. ("Aetna"), on November 28, 2018 (the "Closing Date") the Merger Sub merged with and into Aetna (the "Merger"), with Aetna continuing as the surviving company of the Merger and as a wholly owned subsidiary of CVS Health. Pursuant to the Merger Agreement, on the Closing Date each share of Aetna common stock held by the reporting person was converted into the right to receive 0.8378 of a share of common stock of CVS Health and $145.00 in cash. The closing price of CVS Health's common stock on November 28, 2018 was $80.27 per share.

SEC source: 0001122304-18-000091 · edgar.xml · derivative · entry 3

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,203 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Units convert to Common Stock on a one-for-one basis.

F1 · price: Units convert to Common Stock on a one-for-one basis.

F3 · derivative.exercise_date: Units granted under the Plan. Subject to terms of the Plan, Units vested in four equal installments on August 18, 2017, November 18, 2017, February 18, 2018, and May 18, 2018, with payment of the Units deferred until May 21, 2018.

F3 · derivative.expiration_date: Units granted under the Plan. Subject to terms of the Plan, Units vested in four equal installments on August 18, 2017, November 18, 2017, February 18, 2018, and May 18, 2018, with payment of the Units deferred until May 21, 2018.

SEC source: 0001122304-18-000091 · edgar.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,464

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Units convert to Common Stock on a one-for-one basis.

SEC source: 0001122304-18-000091 · edgar.xml · derivative · entry 2

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 990

Underlying: Common Stock · 990 shares

Expires not disclosed

F1 · derivative.exercise_price: Units convert to Common Stock on a one-for-one basis.

F1 · price: Units convert to Common Stock on a one-for-one basis.

F2 · derivative.exercise_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 18, 2018, November 18, 2018, February 18, 2019, and May 18, 2019, with payment of the Units deferred until May 20, 2019. Upon payment date, Units will be issued in Common Stock.

F2 · derivative.expiration_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 18, 2018, November 18, 2018, February 18, 2019, and May 18, 2019, with payment of the Units deferred until May 20, 2019. Upon payment date, Units will be issued in Common Stock.

SEC source: 0001122304-17-000050 · edgar.xml · derivative · entry 3

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,537 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Units convert to Common Stock on a one-for-one basis.

F1 · price: Units convert to Common Stock on a one-for-one basis.

F3 · derivative.exercise_date: Units granted under the Plan. Subject to terms of the Plan, Units vested in four equal installments on August 20, 2016; November 20, 2016; February 20, 2017, and May 20, 2017, with payment of the Units deferred until May 22, 2017.

F3 · derivative.expiration_date: Units granted under the Plan. Subject to terms of the Plan, Units vested in four equal installments on August 20, 2016; November 20, 2016; February 20, 2017, and May 20, 2017, with payment of the Units deferred until May 22, 2017.

SEC source: 0001122304-17-000050 · edgar.xml · nonDerivative · entry 1

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,261

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Units convert to Common Stock on a one-for-one basis.

SEC source: 0001122304-17-000050 · edgar.xml · derivative · entry 2

AGUIRRE FERNANDO · CIK 0001224983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,203

Underlying: Common Stock · 1,203 shares

Expires not disclosed

F1 · derivative.exercise_price: Units convert to Common Stock on a one-for-one basis.

F1 · price: Units convert to Common Stock on a one-for-one basis.

F2 · derivative.exercise_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 19, 2017; November 19, 2017; February 19, 2018, and May 19, 2018, with payment of the Units deferred until May 21, 2018. Upon payment date, Units will be issued in Common Stock.

F2 · derivative.expiration_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 19, 2017; November 19, 2017; February 19, 2018, and May 19, 2018, with payment of the Units deferred until May 21, 2018. Upon payment date, Units will be issued in Common Stock.